Page last updated: 2024-12-07

3,4-dihydroxymandelic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3,4-dihydroxymandelic acid: metabolite of L-dopa; RN given refers to parent cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

3,4-dihydroxymandelic acid : A catechol that is the 3,4-dihydroxy derivative of mandelic acid; a metabolite of L-dopa. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID85782
CHEBI ID27637
SCHEMBL ID43825
SCHEMBL ID10085813
MeSH IDM0041015

Synonyms (62)

Synonym
mandelic acid, 3,4-dihydroxy-
C05580
775-01-9
dihydroxymandelic acid
3,4-dihydroxymandelic acid
3,4 dihydroxymandelic acid
dl-3,4-dihydroxymandelic acid, 95%
99F40077-4AAD-4A13-8A8E-5B382C0CA42B
D0582
dl-3,4-dihydroxymandelic acid
KUC106683N
ksc-11-207-14
14883-87-5
AKOS003382257
benzeneacetic acid, .alpha.,3,4-trihydroxy-
BMSE000684
d,l-3,4-dihydroxymandelic acid
FT-0667125
2-(3,4-dihydroxyphenyl)-2-hydroxyacetic acid
doma
3,4-dihydroxyphenylglycolic acid
(3,4-dihydroxyphenyl)(hydroxy)acetic acid
CHEBI:27637
A808812
einecs 238-956-8
(1)-3,4-dihydroxyphenylglycolic acid
einecs 212-269-3
wdp6vcx5t6 ,
unii-wdp6vcx5t6
bdbm92714
3,4-dihydroxymandelate, xvi
FT-0625398
gtpl6633
2-(3',4'-dihydroxyphenyl) 2-hydroxyethanoic acid
SCHEMBL43825
SCHEMBL10085813
3',4'-dihydroxymandelic acid
.alpha.,3,4-trihydroxybenzeneacetic acid
(3,4-dihydroxyphenyl)(hydroxy)acetic acid #
(3,4-dihydroxyphenyl)glycolic acid
3,4-dihydroxymandelicacid
mfcd00004231
3,4 dihydroxymandelate
3,4-dihydroxyphenylglycolate
dihydroxymandelate
AS-63147
J-008520
HY-113474
CS-0062359
Q4634064
(+/-)-3,4-dihydroxymandelic acid
rac 3,4-dihydroxymandelic acid
DTXSID30862411
benzeneacetic acid, alpha,3,4-trihydroxy-
M01655
D89682
alpha,3,4-trihydroxybenzeneacetic acid
dl -3,4-dihydroxymandelic acid
PD050678
rac3,4-dihydroxymandelicacid
alpha-hydroxy-3,4-dihydroxyphenylacetic acid
EN300-1842635

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" The bioavailability of both antibiotics appeared to depend on the concentration of the adjuvant in the microenema, the dosage form used in these experiments."( Enhanced rectal absorption of cefmetazole and cefoxitin in the presence of epinephrine metabolites in rats and a high-performance liquid chromatographic assay for cephamycin antibiotics.
Higuchi, T; Nishihata, T; Rytting, JH; Takahagi, H; Tomida, H; Yamamoto, M, 1984
)
0.27

Dosage Studied

ExcerptRelevanceReference
" The bioavailability of both antibiotics appeared to depend on the concentration of the adjuvant in the microenema, the dosage form used in these experiments."( Enhanced rectal absorption of cefmetazole and cefoxitin in the presence of epinephrine metabolites in rats and a high-performance liquid chromatographic assay for cephamycin antibiotics.
Higuchi, T; Nishihata, T; Rytting, JH; Takahagi, H; Tomida, H; Yamamoto, M, 1984
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (4)

RoleDescription
antioxidantA substance that opposes oxidation or inhibits reactions brought about by dioxygen or peroxides.
drug metabolitenull
human metaboliteAny mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
mouse metaboliteAny mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
2-hydroxy monocarboxylic acid
catecholsAny compound containing an o-diphenol component.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (10)

PathwayProteinsCompounds
Tyrosine Metabolism1657
Alkaptonuria1657
Hawkinsinuria1657
Tyrosinemia Type I1657
Disulfiram Action Pathway2366
Tyrosinemia, Transient, of the Newborn1657
Dopamine beta-Hydroxylase Deficiency1657
Monoamine Oxidase-A Deficiency (MAO-A)1657
Tyrosine metabolism ( Tyrosine metabolism )2841
NAD+ + 3,4-Dihydroxy-mandelaldehyde + H2O = NADH + 3,4-Dihydroxy-mandelic acid ( Tyrosine metabolism )45

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Prolyl 4-hydroxylase subunit alpha-1Gallus gallus (chicken)Ki9.00005.00007.66679.0000AID1799825
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (1)

Processvia Protein(s)Taxonomy
peptidyl-proline hydroxylation to 4-hydroxy-L-prolineProlyl 4-hydroxylase subunit alpha-1Gallus gallus (chicken)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (3)

Processvia Protein(s)Taxonomy
procollagen-proline 4-dioxygenase activityProlyl 4-hydroxylase subunit alpha-1Gallus gallus (chicken)
iron ion bindingProlyl 4-hydroxylase subunit alpha-1Gallus gallus (chicken)
L-ascorbic acid bindingProlyl 4-hydroxylase subunit alpha-1Gallus gallus (chicken)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (2)

Processvia Protein(s)Taxonomy
endoplasmic reticulum lumenProlyl 4-hydroxylase subunit alpha-1Gallus gallus (chicken)
endoplasmic reticulumProlyl 4-hydroxylase subunit alpha-1Gallus gallus (chicken)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1799825Inhibition Assay from Article : \\Partial identity of the 2-oxoglutarate and ascorbate binding sites of prolyl 4-hydroxylase.\\1986The Journal of biological chemistry, Jun-15, Volume: 261, Issue:17
Partial identity of the 2-oxoglutarate and ascorbate binding sites of prolyl 4-hydroxylase.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (67)

TimeframeStudies, This Drug (%)All Drugs %
pre-199036 (53.73)18.7374
1990's17 (25.37)18.2507
2000's3 (4.48)29.6817
2010's9 (13.43)24.3611
2020's2 (2.99)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.92

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.92 (24.57)
Research Supply Index4.29 (2.92)
Research Growth Index4.88 (4.65)
Search Engine Demand Index26.67 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (23.92)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (4.35%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other66 (95.65%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]